↓ Skip to main content

RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation in vitro

Overview of attention for article published in Frontiers in oncology, May 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
5 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation in vitro
Published in
Frontiers in oncology, May 2023
DOI 10.3389/fonc.2023.1110939
Pubmed ID
Authors

Tilman L. R. Vogelsang, Verena Kast, Konstantin Bagnjuk, Katja Eubler, Sree Priyanka Jeevanandan, Elisa Schmoeckel, Anna Trebo, Nicole Elisabeth Topalov, Sven Mahner, Doris Mayr, Artur Mayerhofer, Udo Jeschke, Aurelia Vattai

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 40%
Student > Ph. D. Student 1 20%
Unknown 2 40%
Readers by discipline Count As %
Unspecified 2 40%
Biochemistry, Genetics and Molecular Biology 1 20%
Unknown 2 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2023.
All research outputs
#16,421,110
of 25,927,633 outputs
Outputs from Frontiers in oncology
#5,796
of 22,840 outputs
Outputs of similar age
#213,007
of 413,356 outputs
Outputs of similar age from Frontiers in oncology
#237
of 1,166 outputs
Altmetric has tracked 25,927,633 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,840 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 413,356 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,166 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.